Test Bank For Clayton’s Basic Pharmacology for Nurses 19th Editio
sd sd sd sd sd sd sd sd sd
n By Michelle J. Willihnganz, Samuel L. Gurevitz, Bruce Clayton C
sd sd sd sd sd sd sd sd sd sd
omplete
,Chaptersd01:sdDrugsdDefinitions,sdStandards,sdandsdInformationsdSourcessdWillihng
anz:sdClayton’ssdBasicsdPharmacologysdforsdNurses,sd19thsdEdition
MULTIPLEsdCHOICE
1. WhichsdnamesdidentifiessdasddrugsdlistedsdbysdthesdUSsdFoodsd
andsdDrugsdAdministrationsd(FDA)?
a. Brand
b. Nonproprietary
c. Official
d. Trademark
ANS:sd C
Thesdofficialsdnamesdissdthes d namesdundersdwhichsdasddrugsdissdli
stedsdbysdthesdFDA.sdThesdbrandsdname,sdorsdtrademark,sdissdthesd
namesdgivensdtosdasddrugsdbysditssdmanufacturer.sdThesdnonpropr
ietary,sdorsdgeneric,sdnamesdissdprovidedsdbysdthesdUnitedsdStates
sdAdoptedsdNamessdCouncil.
DIF: CognitivesdLevel:sdKnowledge REF:s d p.sd9
OBJ:sd1NAT:sdNCLEXsdClientsdNeedssdCategory:sdSafe,sdEffectivesd
CaresdEnvironmentsdTOP:s d NursingsdProcesssdStep:sdAssessment
CON:sd
PatientsdEducation
2. Whichsdsourcesdcontainssdinformationsdspecificsdtosdnutritionalsdsupplements?
a. USPsdDictionarysdofsdUSANsd &sdInternationalsdDrugsdNames
b. NaturalsdMedicinessdComprehensivesdDatabase
c. UnitedsdStatessdPharmacopoeia/NationalsdFormularysd(USPsdNF)
d. DrugsdInteractionsdFacts
ANS:sd C
UnitedsdStatessdPharmacopoeia/NationalsdFormularysdcontainssdinformationsdspecificsdtosdnutritio
nalsdsupplements.sdUSPsdDictionarysdofsdUSANsd&sdInternationalsdDrugsdNamessdissdasdcompilatio
nsdofsddrugsdnames,sdpronunciationsdguide,sdandsdpossiblesdfuturesdFDAsdapprovedsddrugs;sditsddoes
sdnotsdincludesdnutritionalsdsupplements.sdNaturalsdMedicinessdComprehensivesdDatabasesdcontai
ns
evidence-
basedsdinformationsdonsdherbalsdmedicinessdandsdherbalsdcombinationsdproducts;sditsddoessdnotsdinclu
desdinformationsdspecificsdtosdnutritionalsdsupplements.sdDrugsdInteractionsdFactssdcontainssdcom
prehensivesdinformationsdonsddrugsdinteractionsdfacts;sditsddoessdnotsdincludesdnutritionalsdsupplem
ents.
DIF: CognitivesdLevel:sdKnowledge REF:s d p.sd4
OBJ:sd3sdNAT:s d NCLEXsdClientsdNeedssdCategory:sdPhysiologicalsd
Integrity
TOP:s d NursingsdProcesssdStep:sdAssessment CON:s d Nutritionsd|sdPatientsdEducation
3. Whichsddrugsdreferencesdcontainssddrugsdmonographssdthatsddescribesdallsddrugssdinsdasdtherapeuticsdclass?
a. DrugsdFactssdandsdComparisons
,TestsdBanksdForsdClayton’ssdBasicsdPharmacologysdforsdNursessd19thsdEd 3
ition
b. DrugsdInteractionsdFacts
c. HandbooksdonsdInjectablesdDrugs
d. Martindale—ThesdCompletesdDrugsdReference
ANS:sd A
DrugsdFactssdandsdComparisonssdcontainssddrugsdmonographssdthatsddescribesdallsddrugssd
insdasdtherapeuticsdclass.sdMonographssdaresdformattedsdassdtablessdtosdallowsdcomparisonsdof
sdsimilarsdproducts,sdbrandsdnames,sdmanufacturers,sdcostsdindices,sdandsdavailablesddosag
esdformssdOnlinesdversionsdissdavailable.
DIF: CognitivesdLevel:sdKnowledge REF:s d p.sd4sdTablesd1.2
OBJ:s d s d 3 NAT:s d NCLEXsdClientsdNeedssdCategory:sdPhysiologicalsdIntegrity
TOP:s d NursingsdProcesssdStep:sdAssessment CON:s d Safetysd|sdPatientsdEducationsd|sdClinicalsdJudgment
4. Whichsddrugsdreferencesdcontainssdmonographssdaboutsdvirtuallysdeverysdsingle-
entitysddrugsdavailablesdinsdthesdUnitedsdStatessdandsddescribessdtherapeuticsdusessdofsddrugs,sdinclu
dingsdapprovedsdandsdunapprovedsduses?
a. Martindale:sdThesdCompletesdDrugsdReference
b. AHFSsdDrugsdInformation
c. DrugsdReference
d. DrugsdFactssdandsdComparisons
ANS:sd B
AHFSsdDrugsdInformationsdcontainssdmonographssdaboutsdvirtuallysdeverysdsingle-
entitysddrugsdavailablesdinsdthesdUnitedsdStatessdandsddescribessdtherapeuticsdusessdofsddrugs,sdincludi
ngsdapprovedsdandsdunapprovedsduses.
DIF: CognitivesdLevel:sdKnowledge REF:s d p.sd4sdTablesd1.2
OBJ:s d s d 3 NAT:s d NCLEXsdClientsdNeedssdCategory:sdPhysiologicalsdIntegrity
TOP:s d NursingsdProcesssdStep:sdPlanning CON:s d Safetysd|sdPatientsdEducationsd|sdClinicalsdJudgment
5. Whichsdonlinesddrugsdreferencesdmakessdavailablesdtosdhealthcaresdproviderssdandsdthesdpublics
a standard,sdcomprehensive,sdup-to-
d sd
datesdlooksdupsdandsddownloadablesdresourcesdaboutsdmedicines?
a. AmericansdDrugsdIndex
b. AmericansdHospitalsdFormulary
c. DailyMed
d. DrugsdReference
ANS:sd C
DailyMedsdmakessdavailablesdtosdhealthcaresdproviderssdandsdthesdpublicsdasdstandard,sdcomprehen
sive,sdup-to-
datesdlooksdupsdandsddownloadablesdresourcesdaboutsdmedicines.sdThesdAmericansdDrugsdIndexsdissd
notsdappropriatesdforsdpatientsduse.sdThesdAmericansdHospitalsdFormularysdissdnotsdappropriatesdf
orsdpatientsduse.sdThesddrugsdreferencesdissdnotsdappropriatesdforsdpatientsduse.
DIF: CognitivesdLevel:sdKnowledge REF:s d p.sd3sd|sdp.sd4
OBJ:sd3sdNAT:s d NCLEXsdClientsdNeedssdCategory:sdPhysiologicalsd
Integrity
TOP:sd NursingsdProcesssdStep:sdImplementation
CON:s d Safetysd|sdPatientsdEducationsd|sdClinicalsdJudgment
6. WhichsdlegislationsdauthorizessdthesdFDAsdtosddeterminesdthesdsafetysdofsdasddrugsdbeforesditssdmarketing?
a. FederalsdFood,sdDrug,sdandsdCosmeticsdActsd(1938)
b. DurhamsdHumphreysdAmendmentsd(1952)
, TestsdBanksdForsdClayton’ssdBasicsdPharmacologysdforsdNursessd19thsdEd 4
ition
c. ControlledsdSubstancessdActsd(1970)
d. KefauversdHarrissdDrugsdAmendmentsd(1962)
ANS:sd A
ThesdFederalsdFood,sdDrug,sdandsdCosmeticsdActsdofsd1938sdauthorizedsdthesdFDAsdtosddeterminesdt
hesdsafetysdofsdallsddrugssdbeforesdmarketing.sdLatersdamendmentssdandsdactssdhelpedsdtightensdFD
Asdcontrolsdandsdensuresddrugsdsafety.sdThesdDurhamsdHumphreysdAmendmentsddefinessdthesdkind
ssdofsddrugssdthatsdcannotsdbesdusedsdsafelysdwithoutsdmedicalsdsupervisionsdandsdrestrictssdtheirsdsal
esdtosdprescriptionsdbysdasdlicensedsdpractitioner.sdThesdControlledsdSubstancessdActsdaddressessdonl
ysdcontrolledsdsubstancessdandsdtheirsdcategorization.sdThesdKefauversdHarrissdDrugsdAmendmentsd
ensuressddrugsdefficacysdandsdgreatersddrugsdsafety.sdDrugsdmanufacturerssdaresdrequiredsdtosdproves
dtosdthesdFDAsdthesdeffectivenesssdofsdtheirsdproductssdbeforesdmarketingsdthem.
DIF: CognitivesdLevel:sdKnowledge REF:s d p.sd5sdTablesdl.3
OBJ:s d 5
NAT:sdNCLEXsdClientsdNeedssdCategory:sdPhysiologicalsdIntegr
itysdTOP:s d NursingsdProcesssdStep:sdAssessment
CON:s d Safetysd|sdPatientsdEducationsd|sdEvidencesd|sdHealthsdCaresdLaw
7. Whichsdclassificationsddoessdmeperidinesd(Demerol)sdfallsdunder?
a. I
b. II
c. III
d. IV
ANS:sd B
Meperidinesd(Demerol)sdissdasdSchedulesdIIsddrug;sditsdhassdasdhighsdpotentialsdforsdabusesdandsdmaysd
leadsdtosdseveresdpsychologicalsdandsdphysicalsddependence.sdSchedulesdIsddrugssdhavesdhighsdpotenti
alsdforsdabusesdandsdnosdrecognizedsdmedicalsduse.sdSchedulesdIIIsddrugssdhavesdsomesdpotentialsdfors
dabuse.sdUsesdmaysdleadsdtosdlowsdtosdmoderatesdphysicalsddependencesdorsdhighsdpsychological sdde
pendence.sdSchedulesdIVsddrugssdhavesdlowsdpotentialsdforsdabuse.sdUsesdmaysdleadsdtosdlimitedsdph
ysicalsdorsdpsychologicalsddependence.
DIF: CognitivesdLevel:sdKnowledge REF:s d p.sd10
OBJ:sd2sdNAT:s d NCLEXsdClientsdNeedssdCategory:sdSafe,sdEffectiv
esdCaresdEnvironment
TOP:s d NursingsdProcesssdStep:sdAssessment CON:s d PatientsdEducationsd|sdAddictionsd|sdPain
8. WhichsdactionsdwouldsdthesdFDAsdtakesdtosdexpeditesddrugsddevelopmentsdandsdapprovalsdforsdansdout
breaksdofsdsmallpox?
a. Listsdsmallpoxsdassdasdhealthsdorphansddisease.
b. Omitsdthesdpreclinicalsdresearchsdphase.
c. Extendsdthesdclinicalsdresearchsdphase.
d. Fastsdtracksdthesdinvestigationalsddrug.
ANS:sd D
OncesdthesdInvestigationalsdNewsdDrugsdApplicationsdhassdbeensdapproved,sdthesddrugsdcansdreceiv
esdhighestsdprioritysdwithinsdthesdagency,sdwhichsdissdcalledsdfastsdtracking.sdAsdsmallpoxsdoutbreak
sdwouldsdbecomesdasdprioritysdconcernsdinsdthesdworld.sdOrphansddiseasessdaresdnotsdresearchedsdinsd
asdprioritysdmanner.sdPreclinicalsdresearchsdissdnotsdomitted.sdExtendingsdanysdphasesdofsdthesdresea
rchsdwouldsdmeansdasdlongersdtimesdtosddevelopsdasdvaccine.sdThesdFDAsdmustsdensuresdthatsdallsdphas
essdofsdthesdpreclinicalsdandsdclinicalsdresearchsdphasesdhavesdbeensdcompletedsdinsdasdsafesdmanner.
DIF: CognitivesdLevel:sdKnowledge REF:s d s d p.sd7 OBJ:sd 5
sd sd sd sd sd sd sd sd sd
n By Michelle J. Willihnganz, Samuel L. Gurevitz, Bruce Clayton C
sd sd sd sd sd sd sd sd sd sd
omplete
,Chaptersd01:sdDrugsdDefinitions,sdStandards,sdandsdInformationsdSourcessdWillihng
anz:sdClayton’ssdBasicsdPharmacologysdforsdNurses,sd19thsdEdition
MULTIPLEsdCHOICE
1. WhichsdnamesdidentifiessdasddrugsdlistedsdbysdthesdUSsdFoodsd
andsdDrugsdAdministrationsd(FDA)?
a. Brand
b. Nonproprietary
c. Official
d. Trademark
ANS:sd C
Thesdofficialsdnamesdissdthes d namesdundersdwhichsdasddrugsdissdli
stedsdbysdthesdFDA.sdThesdbrandsdname,sdorsdtrademark,sdissdthesd
namesdgivensdtosdasddrugsdbysditssdmanufacturer.sdThesdnonpropr
ietary,sdorsdgeneric,sdnamesdissdprovidedsdbysdthesdUnitedsdStates
sdAdoptedsdNamessdCouncil.
DIF: CognitivesdLevel:sdKnowledge REF:s d p.sd9
OBJ:sd1NAT:sdNCLEXsdClientsdNeedssdCategory:sdSafe,sdEffectivesd
CaresdEnvironmentsdTOP:s d NursingsdProcesssdStep:sdAssessment
CON:sd
PatientsdEducation
2. Whichsdsourcesdcontainssdinformationsdspecificsdtosdnutritionalsdsupplements?
a. USPsdDictionarysdofsdUSANsd &sdInternationalsdDrugsdNames
b. NaturalsdMedicinessdComprehensivesdDatabase
c. UnitedsdStatessdPharmacopoeia/NationalsdFormularysd(USPsdNF)
d. DrugsdInteractionsdFacts
ANS:sd C
UnitedsdStatessdPharmacopoeia/NationalsdFormularysdcontainssdinformationsdspecificsdtosdnutritio
nalsdsupplements.sdUSPsdDictionarysdofsdUSANsd&sdInternationalsdDrugsdNamessdissdasdcompilatio
nsdofsddrugsdnames,sdpronunciationsdguide,sdandsdpossiblesdfuturesdFDAsdapprovedsddrugs;sditsddoes
sdnotsdincludesdnutritionalsdsupplements.sdNaturalsdMedicinessdComprehensivesdDatabasesdcontai
ns
evidence-
basedsdinformationsdonsdherbalsdmedicinessdandsdherbalsdcombinationsdproducts;sditsddoessdnotsdinclu
desdinformationsdspecificsdtosdnutritionalsdsupplements.sdDrugsdInteractionsdFactssdcontainssdcom
prehensivesdinformationsdonsddrugsdinteractionsdfacts;sditsddoessdnotsdincludesdnutritionalsdsupplem
ents.
DIF: CognitivesdLevel:sdKnowledge REF:s d p.sd4
OBJ:sd3sdNAT:s d NCLEXsdClientsdNeedssdCategory:sdPhysiologicalsd
Integrity
TOP:s d NursingsdProcesssdStep:sdAssessment CON:s d Nutritionsd|sdPatientsdEducation
3. Whichsddrugsdreferencesdcontainssddrugsdmonographssdthatsddescribesdallsddrugssdinsdasdtherapeuticsdclass?
a. DrugsdFactssdandsdComparisons
,TestsdBanksdForsdClayton’ssdBasicsdPharmacologysdforsdNursessd19thsdEd 3
ition
b. DrugsdInteractionsdFacts
c. HandbooksdonsdInjectablesdDrugs
d. Martindale—ThesdCompletesdDrugsdReference
ANS:sd A
DrugsdFactssdandsdComparisonssdcontainssddrugsdmonographssdthatsddescribesdallsddrugssd
insdasdtherapeuticsdclass.sdMonographssdaresdformattedsdassdtablessdtosdallowsdcomparisonsdof
sdsimilarsdproducts,sdbrandsdnames,sdmanufacturers,sdcostsdindices,sdandsdavailablesddosag
esdformssdOnlinesdversionsdissdavailable.
DIF: CognitivesdLevel:sdKnowledge REF:s d p.sd4sdTablesd1.2
OBJ:s d s d 3 NAT:s d NCLEXsdClientsdNeedssdCategory:sdPhysiologicalsdIntegrity
TOP:s d NursingsdProcesssdStep:sdAssessment CON:s d Safetysd|sdPatientsdEducationsd|sdClinicalsdJudgment
4. Whichsddrugsdreferencesdcontainssdmonographssdaboutsdvirtuallysdeverysdsingle-
entitysddrugsdavailablesdinsdthesdUnitedsdStatessdandsddescribessdtherapeuticsdusessdofsddrugs,sdinclu
dingsdapprovedsdandsdunapprovedsduses?
a. Martindale:sdThesdCompletesdDrugsdReference
b. AHFSsdDrugsdInformation
c. DrugsdReference
d. DrugsdFactssdandsdComparisons
ANS:sd B
AHFSsdDrugsdInformationsdcontainssdmonographssdaboutsdvirtuallysdeverysdsingle-
entitysddrugsdavailablesdinsdthesdUnitedsdStatessdandsddescribessdtherapeuticsdusessdofsddrugs,sdincludi
ngsdapprovedsdandsdunapprovedsduses.
DIF: CognitivesdLevel:sdKnowledge REF:s d p.sd4sdTablesd1.2
OBJ:s d s d 3 NAT:s d NCLEXsdClientsdNeedssdCategory:sdPhysiologicalsdIntegrity
TOP:s d NursingsdProcesssdStep:sdPlanning CON:s d Safetysd|sdPatientsdEducationsd|sdClinicalsdJudgment
5. Whichsdonlinesddrugsdreferencesdmakessdavailablesdtosdhealthcaresdproviderssdandsdthesdpublics
a standard,sdcomprehensive,sdup-to-
d sd
datesdlooksdupsdandsddownloadablesdresourcesdaboutsdmedicines?
a. AmericansdDrugsdIndex
b. AmericansdHospitalsdFormulary
c. DailyMed
d. DrugsdReference
ANS:sd C
DailyMedsdmakessdavailablesdtosdhealthcaresdproviderssdandsdthesdpublicsdasdstandard,sdcomprehen
sive,sdup-to-
datesdlooksdupsdandsddownloadablesdresourcesdaboutsdmedicines.sdThesdAmericansdDrugsdIndexsdissd
notsdappropriatesdforsdpatientsduse.sdThesdAmericansdHospitalsdFormularysdissdnotsdappropriatesdf
orsdpatientsduse.sdThesddrugsdreferencesdissdnotsdappropriatesdforsdpatientsduse.
DIF: CognitivesdLevel:sdKnowledge REF:s d p.sd3sd|sdp.sd4
OBJ:sd3sdNAT:s d NCLEXsdClientsdNeedssdCategory:sdPhysiologicalsd
Integrity
TOP:sd NursingsdProcesssdStep:sdImplementation
CON:s d Safetysd|sdPatientsdEducationsd|sdClinicalsdJudgment
6. WhichsdlegislationsdauthorizessdthesdFDAsdtosddeterminesdthesdsafetysdofsdasddrugsdbeforesditssdmarketing?
a. FederalsdFood,sdDrug,sdandsdCosmeticsdActsd(1938)
b. DurhamsdHumphreysdAmendmentsd(1952)
, TestsdBanksdForsdClayton’ssdBasicsdPharmacologysdforsdNursessd19thsdEd 4
ition
c. ControlledsdSubstancessdActsd(1970)
d. KefauversdHarrissdDrugsdAmendmentsd(1962)
ANS:sd A
ThesdFederalsdFood,sdDrug,sdandsdCosmeticsdActsdofsd1938sdauthorizedsdthesdFDAsdtosddeterminesdt
hesdsafetysdofsdallsddrugssdbeforesdmarketing.sdLatersdamendmentssdandsdactssdhelpedsdtightensdFD
Asdcontrolsdandsdensuresddrugsdsafety.sdThesdDurhamsdHumphreysdAmendmentsddefinessdthesdkind
ssdofsddrugssdthatsdcannotsdbesdusedsdsafelysdwithoutsdmedicalsdsupervisionsdandsdrestrictssdtheirsdsal
esdtosdprescriptionsdbysdasdlicensedsdpractitioner.sdThesdControlledsdSubstancessdActsdaddressessdonl
ysdcontrolledsdsubstancessdandsdtheirsdcategorization.sdThesdKefauversdHarrissdDrugsdAmendmentsd
ensuressddrugsdefficacysdandsdgreatersddrugsdsafety.sdDrugsdmanufacturerssdaresdrequiredsdtosdproves
dtosdthesdFDAsdthesdeffectivenesssdofsdtheirsdproductssdbeforesdmarketingsdthem.
DIF: CognitivesdLevel:sdKnowledge REF:s d p.sd5sdTablesdl.3
OBJ:s d 5
NAT:sdNCLEXsdClientsdNeedssdCategory:sdPhysiologicalsdIntegr
itysdTOP:s d NursingsdProcesssdStep:sdAssessment
CON:s d Safetysd|sdPatientsdEducationsd|sdEvidencesd|sdHealthsdCaresdLaw
7. Whichsdclassificationsddoessdmeperidinesd(Demerol)sdfallsdunder?
a. I
b. II
c. III
d. IV
ANS:sd B
Meperidinesd(Demerol)sdissdasdSchedulesdIIsddrug;sditsdhassdasdhighsdpotentialsdforsdabusesdandsdmaysd
leadsdtosdseveresdpsychologicalsdandsdphysicalsddependence.sdSchedulesdIsddrugssdhavesdhighsdpotenti
alsdforsdabusesdandsdnosdrecognizedsdmedicalsduse.sdSchedulesdIIIsddrugssdhavesdsomesdpotentialsdfors
dabuse.sdUsesdmaysdleadsdtosdlowsdtosdmoderatesdphysicalsddependencesdorsdhighsdpsychological sdde
pendence.sdSchedulesdIVsddrugssdhavesdlowsdpotentialsdforsdabuse.sdUsesdmaysdleadsdtosdlimitedsdph
ysicalsdorsdpsychologicalsddependence.
DIF: CognitivesdLevel:sdKnowledge REF:s d p.sd10
OBJ:sd2sdNAT:s d NCLEXsdClientsdNeedssdCategory:sdSafe,sdEffectiv
esdCaresdEnvironment
TOP:s d NursingsdProcesssdStep:sdAssessment CON:s d PatientsdEducationsd|sdAddictionsd|sdPain
8. WhichsdactionsdwouldsdthesdFDAsdtakesdtosdexpeditesddrugsddevelopmentsdandsdapprovalsdforsdansdout
breaksdofsdsmallpox?
a. Listsdsmallpoxsdassdasdhealthsdorphansddisease.
b. Omitsdthesdpreclinicalsdresearchsdphase.
c. Extendsdthesdclinicalsdresearchsdphase.
d. Fastsdtracksdthesdinvestigationalsddrug.
ANS:sd D
OncesdthesdInvestigationalsdNewsdDrugsdApplicationsdhassdbeensdapproved,sdthesddrugsdcansdreceiv
esdhighestsdprioritysdwithinsdthesdagency,sdwhichsdissdcalledsdfastsdtracking.sdAsdsmallpoxsdoutbreak
sdwouldsdbecomesdasdprioritysdconcernsdinsdthesdworld.sdOrphansddiseasessdaresdnotsdresearchedsdinsd
asdprioritysdmanner.sdPreclinicalsdresearchsdissdnotsdomitted.sdExtendingsdanysdphasesdofsdthesdresea
rchsdwouldsdmeansdasdlongersdtimesdtosddevelopsdasdvaccine.sdThesdFDAsdmustsdensuresdthatsdallsdphas
essdofsdthesdpreclinicalsdandsdclinicalsdresearchsdphasesdhavesdbeensdcompletedsdinsdasdsafesdmanner.
DIF: CognitivesdLevel:sdKnowledge REF:s d s d p.sd7 OBJ:sd 5
